Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

360
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
360
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

414
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
414
Bioequivalence: Overview01:16

Bioequivalence: Overview

2.3K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
2.3K
Equivalence: In Vitro and In Vivo Bioequivalence01:17

Equivalence: In Vitro and In Vivo Bioequivalence

371
Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts. Pharmaceutical...
371
Immunological Memory01:23

Immunological Memory

18.1K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
18.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A portable target-triggered fluorogenic RNA switch functionalized hydrogel kit for rapid visual detection of miRNA-126 in colorectal cancer.

Analytica chimica acta·2026
Same author

The 'sugar' side of extracellular vesicle-glycome: a panorama from basic characteristics, deciphering technologies, functions, to applications.

Journal of nanobiotechnology·2026
Same author

Development of an electrochemiluminescence immunoassay for quantitative determination of semaglutide in human serum.

Analytical biochemistry·2026
Same author

Droplet-Based Facile Deciphering of Heterogeneous Glycans in Extracellular Vesicles down to the Single-Particle Level.

Analytical chemistry·2026
Same author

The Efficacy of a Human-Ready mini<i>MECP2</i> Gene Therapy in a Pre-Clinical Model of Rett Syndrome.

Genes·2024
Same author

Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ASPIRO open-label clinical trial.

EBioMedicine·2023

Related Experiment Video

Updated: Apr 17, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.3K

Comparative immunogenicity assessment: a critical consideration for biosimilar development.

Patrick M Liu1, Linglong Zou, Chanchal Sadhu

  • 1Global Bioassays & Technology, Teva Pharmaceuticals, 145 Brandywine Parkway, West Chester, PA 19380, USA.

Bioanalysis
|February 21, 2015
PubMed
Summary
This summary is machine-generated.

Developing validated anti-drug antibody (ADA) assays is crucial for comparing biosimilar immunogenicity. Strategies should detect immune response differences, ensuring assay performance meets comparative assessment needs for biosimilar evaluation.

More Related Videos

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

10.5K
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

13.6K

Related Experiment Videos

Last Updated: Apr 17, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.3K
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

10.5K
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

13.6K

Area of Science:

  • Biopharmaceutical analysis
  • Immunology
  • Drug development

Background:

  • Comparative immunogenicity assessment is vital for biosimilar approval.
  • Anti-drug antibody (ADA) assays are key tools in this evaluation.
  • Current strategies often recommend using the biosimilar as the detecting reagent.

Purpose of the Study:

  • To outline an appropriate assessment strategy for comparative immunogenicity evaluation of biosimilars.
  • To highlight the importance of validated ADA assays in identifying potential immune response differences.
  • To discuss the utility of product-specific ADA assays.

Main Methods:

  • Review of current practices in ADA assay development for biosimilar immunogenicity.
  • Discussion of assay strategies, including the use of biosimilar vs. product-specific reagents.
  • Emphasis on the necessity of full assay performance assessment and validation.

Main Results:

  • A comprehensive assessment strategy using validated ADA assays is critical.
  • Both general ADA assay approaches and product-specific assays have roles in immunogenicity evaluation.
  • Thorough assay validation is mandatory for comparative purposes.

Conclusions:

  • Validated ADA assays are essential for robust biosimilar immunogenicity assessment.
  • Assay strategy selection should focus on detecting potential immune differences.
  • Rigorous validation ensures the reliability of comparative immunogenicity data.